RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
PTC Therapeutics Stock

PTC Therapeutics Debt 2024

PTC Therapeutics Debt

1,524.49 USD

Ticker

PTCT

ISIN

US69366J2006

WKN

A1W0MW

In 2024, PTC Therapeutics's total debt was 1,524.49 USD, a 42.28% change from the 1,071.5 USD total debt recorded in the previous year.

PTC Therapeutics Aktienanalyse

What does PTC Therapeutics do?

PTC Therapeutics Inc. is a biopharmaceutical company based in South Plainfield, New Jersey. The company was founded in 1998 and focuses on the research and development of drugs for the treatment of rare diseases. The company has two main divisions: product research and development, and science and innovation. Its product range includes several drugs for the treatment of rare diseases such as Duchenne muscular dystrophy, spinal muscular atrophy, and cystic fibrosis. One of its key products is Translarna, the first RNA-targeted drug approved for the treatment of Duchenne muscular dystrophy. Another product is Evrysdi, approved for the treatment of spinal muscular atrophy. PTC Therapeutics also has a pipeline of drugs being tested in clinical trials for various rare diseases. The company is committed to promoting innovation and has partnerships with academic institutions and other companies to explore and develop new therapies. Overall, PTC Therapeutics aims to improve the lives of patients with rare diseases through innovative treatments. PTC Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding PTC Therapeutics's Debt Structure

PTC Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing PTC Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to PTC Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in PTC Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about PTC Therapeutics stock

What is the debt of PTC Therapeutics this year?

PTC Therapeutics has a debt level of 1,524.49 USD this year.

What was the debt of PTC Therapeutics compared to the previous year?

The debt of PTC Therapeutics has increased by 42.28% compared to the previous year increased.

What are the consequences of high debt for investors in PTC Therapeutics?

High debt can pose a risk for investors of PTC Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of PTC Therapeutics?

Low debt means that PTC Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from PTC Therapeutics affect the company?

An increase in debt of PTC Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of PTC Therapeutics affect the company?

A reduction in debt of PTC Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of PTC Therapeutics?

Some factors that can influence the debt of PTC Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of PTC Therapeutics so important for investors?

The debts of PTC Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can PTC Therapeutics take to change the debt?

To change the debt, PTC Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does PTC Therapeutics pay?

Over the past 12 months, PTC Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PTC Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of PTC Therapeutics?

The current dividend yield of PTC Therapeutics is .

When does PTC Therapeutics pay dividends?

PTC Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PTC Therapeutics?

PTC Therapeutics paid dividends every year for the past 0 years.

What is the dividend of PTC Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is PTC Therapeutics located?

PTC Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von PTC Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PTC Therapeutics from 9/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did PTC Therapeutics pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of PTC Therapeutics in the year 2023?

In the year 2023, PTC Therapeutics distributed 0 USD as dividends.

In which currency does PTC Therapeutics pay out the dividend?

The dividends of PTC Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PTC Therapeutics

Our stock analysis for PTC Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PTC Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.